MONOCLONAL GAMMOPATHY

Clinical trials for MONOCLONAL GAMMOPATHY explained in plain language.

Never miss a new study

Get alerted when new MONOCLONAL GAMMOPATHY trials appear

Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

Drug trial aims to stop cancer before it starts

Prevention Ongoing

This study is testing whether the drug daratumumab can prevent or delay the progression to active multiple myeloma in people with high-risk early-stage conditions. It involves 42 adults with either high-risk MGUS or low-risk smoldering multiple myeloma. The goal is to see if this…

Matched conditions: MONOCLONAL GAMMOPATHY

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention

Last updated Apr 03, 2026 14:42 UTC

MONOCLONAL GAMMOPATHY

Get alerted when new MONOCLONAL GAMMOPATHY trials appear

Drug trial aims to stop cancer before it starts